Cellico (CEO Kim Jungsuk) won CES Innovation Awards in three categories: Wearable Technologies, Digital Health, and Accessibility & Aging Tech, for their augmented reality (AR) smart glasses (product name: EyeCane), which they are developing for visually impaired patients.
With this award, Cellico will participate in the CES exhibition in Las Vegas, USA (January 9 ~ 12, 2024) for the second consecutive year.
CES (Consumer Electronics Show) is a global exhibition where leading players in the consumer electronics technology industry gather to showcase cutting-edge high-tech technologies for the past 50 years. Every year, companies that have achieved technological innovations in 29 fields are selected to receive innovation awards, and each company can receive support for up to three categories of innovation awards. Cellico, by winning innovation awards for two consecutive years and, unusually, in three categories at CES 2024, has once again validated its excellent technological capabilities.
Cellico’s AR glasses, EyeCane, which won the Innovation Awards, is equipped with patient-customized features that use various image processing techniques to replay areas not visible to visually impaired patients, captured by a high-resolution camera. Through Cellico ‘s independently developed big data-based Visual Field Test program, it enables easy monitoring of patients’ visual acuity measurements and visual blind spots. It is expected to help 220 million visually impaired patients worldwide. The technology has already been patented, and production is planned for the first half of 2024 for entry into the overseas market.
Kim Jungsuk, the company CEO, said, “I am pleased that Cellico’s technological capabilities have been recognized globally through winning Innovation Awards in three categories at CES. We are currently attracting investment for product production and will strive to complete product development in the first half of next year to help patients with visual impairment, including macular degeneration, glaucoma, diabetic retinopathy, and retinal detachment.”
Cellico, celebrating its fourth year since its establishment in 2019, holds 30 intellectual property rights. Additionally, it has been consistently recognized for its technological capabilities externally, including being selected for the ‘TIPS Program’ since 2021, winning the top prize in the Gyeonggi Province-led ‘New Gyeonggi Startup Contest,’ selection for Gyeonggi Private Investment-Linked Technology Startup Support, and being selected as a resident company of Pangyo Startup Zone operated by the Korea Innovation Center and Gyeonggi Creative Economy Innovation Center.
For inquiries and connections with Korean tech companies mentioned in this article, contact us at [email protected]. We’re here to facilitate valuable partnerships.